Rachel Greenup, MD, MPH

• Cary Gross
• Ira Leeds
• Lajos Pusztai
• Maryam Lustberg
• Mehra Golshan
• Michael Cecchini
• Michael S. Leapman
• Michaela Dinan
• Tara Sanft
• Tristen Park

Breast Diseases

• Patient Preferences for Postmastectomy Breast ReconstructionShammas R, Hung A, Mullikin A, Sergesketter A, Lee C, Reed S, Fish L, Greenup R, Hollenbeck S. Patient Preferences for Postmastectomy Breast Reconstruction. JAMA Surgery 2023, 158: 1285-1292. PMID: 37755818, PMCID: PMC10535024, DOI: 10.1001/jamasurg.2023.4432.
• Correction: Implementation of an educational intervention to improve medical student cost awareness: a prospective cohort studyTait S, Oshima S, Leraas H, Gunn A, Sarver M, Gunes F, Greenup R. Correction: Implementation of an educational intervention to improve medical student cost awareness: a prospective cohort study. BMC Medical Education 2023, 23: 792. PMID: 37880700, PMCID: PMC10598904, DOI: 10.1186/s12909-023-04797-x.
• Expanding Endocrine Therapy Options for Patients With Ductal Carcinoma In Situ—More Work to DoPlichta J, Greenup R. Expanding Endocrine Therapy Options for Patients With Ductal Carcinoma In Situ—More Work to Do. JAMA Surgery 2023, 158: 1274-1274. PMID: 37870941, DOI: 10.1001/jamasurg.2023.5111.
• Where Are the Children? A Thematic Analysis of State, Territory, and Tribal Organization Comprehensive Cancer Control PlansLeraas H, Beckhorn C, Washabaugh C, Thamby J, Greenup R, Haines K, Allen L, Tracy E. Where Are the Children? A Thematic Analysis of State, Territory, and Tribal Organization Comprehensive Cancer Control Plans. Journal Of Pediatric Surgery 2023, 59: 129-133. PMID: 37858391, DOI: 10.1016/j.jpedsurg.2023.09.022.
• Defining Priorities in Value-Based Cancer Care: Insights From the Alliance for Clinical Trials in Oncology National Cooperative Group SurveyAllen C, Snyder R, Horn D, Hudson M, Barber A, Smieliauskas F, Spears P, Edge S, Greenup R. Defining Priorities in Value-Based Cancer Care: Insights From the Alliance for Clinical Trials in Oncology National Cooperative Group Survey. JCO Oncology Practice 2023, 19: 932-938. PMID: 37651652, PMCID: PMC10615548, DOI: 10.1200/op.23.00159.
• Using Crowdfunding Campaigns to Examine Financial Toxicity and Logistical Burdens Facing Families of Children With Wilms TumorLeraas H, Moya-Mendez M, Donohue V, Kawano B, Olson L, Sekar A, Robles J, Wagner L, Greenup R, Haines K, Tracy E. Using Crowdfunding Campaigns to Examine Financial Toxicity and Logistical Burdens Facing Families of Children With Wilms Tumor. Journal Of Surgical Research 2023, 291: 640-645. PMID: 37542779, DOI: 10.1016/j.jss.2023.07.005.
• Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the USKc M, Fan J, Hyslop T, Hassan S, Cecchini M, Wang S, Silber A, Leapman M, Leeds I, Wheeler S, Spees L, Gross C, Lustberg M, Greenup R, Justice A, Oeffinger K, Dinan M. Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US. JAMA Network Open 2023, 6: e2323115. PMID: 37436746, PMCID: PMC10339147, DOI: 10.1001/jamanetworkopen.2023.23115.
• Pediatric renal malignancy diagnosis is associated with significant burden of care for familiesLeraas H, Thompson S, Sandoe E, Robles J, Wagner L, Scales C, Gow K, Ehrlich P, Greenup R, Tracy E. Pediatric renal malignancy diagnosis is associated with significant burden of care for families. Pediatric Blood & Cancer 2023, 70: e30494. PMID: 37337248, DOI: 10.1002/pbc.30494.
• Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse PopulationChan V, Heller D, Berger E, Capozza S, Greenup R, Sanft T. Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse Population. Annals Of Surgical Oncology 2023, 30: 5637-5648. PMID: 37266804, DOI: 10.1245/s10434-023-13431-5.
• ASO Visual Abstract: Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse PopulationChan V, Heller D, Berger E, Capozza S, Greenup R, Sanft T. ASO Visual Abstract: Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse Population. Annals Of Surgical Oncology 2023, 30: 5651-5652. DOI: 10.1245/s10434-023-13610-4.
• Comparison of incident breast cancer cases in the largest national US tumor registries.Plichta J, Thomas S, Record S, Hyslop T, Hwang E, Greenup R. Comparison of incident breast cancer cases in the largest national US tumor registries. Journal Of Clinical Oncology 2023, 41: 6512-6512. DOI: 10.1200/jco.2023.41.16_suppl.6512.
• Racioethnic differences in missing data in the national cancer database: A window into inequities in cancer care.Raman V, Migaly J, Greenup R, Tong B, Fayanju O. Racioethnic differences in missing data in the national cancer database: A window into inequities in cancer care. Journal Of Clinical Oncology 2023, 41: e18502-e18502. DOI: 10.1200/jco.2023.41.16_suppl.e18502.
• Multidimensional financial hardship among uninsured and insured young adult patients with metastatic breast cancerWheeler S, Spencer J, Manning M, Samuel C, Reeder‐Hayes K, Greenup R, Spees L, Rosenstein D. Multidimensional financial hardship among uninsured and insured young adult patients with metastatic breast cancer. Cancer Medicine 2023, 12: 11930-11940. PMID: 37148550, PMCID: PMC10242847, DOI: 10.1002/cam4.5885.
• Implementation of an educational intervention to improve medical student cost awareness: a prospective cohort studyTait S, Oshima S, Leeras H, Gunn A, Sarver M, Gunes F, Greenup R. Implementation of an educational intervention to improve medical student cost awareness: a prospective cohort study. BMC Medical Education 2023, 23: 73. PMID: 36717888, PMCID: PMC9885673, DOI: 10.1186/s12909-023-04038-1.
• Surgery in the Setting of Metastatic Breast CancerPlichta J, Taskindoust M, Greenup R. Surgery in the Setting of Metastatic Breast Cancer. Current Breast Cancer Reports 2023, 15: 37-47. DOI: 10.1007/s12609-023-00476-4.
• Modifiable Barriers and Facilitators for Breast Cancer Care: A Thematic Analysis of Patient and Provider PerspectivesFayanju O, Greenup R, Zafar S, Hyslop T, Hwang E, Fish L. Modifiable Barriers and Facilitators for Breast Cancer Care: A Thematic Analysis of Patient and Provider Perspectives. Journal Of Surgical Research 2023, 284: 269-279. PMID: 36610386, PMCID: PMC10020986, DOI: 10.1016/j.jss.2022.11.074.
• Genetic testing in privately insured women with surgically treated breast cancerDinan M, Pitafi S, Greenup R, Long J, Gross C. Genetic testing in privately insured women with surgically treated breast cancer. Breast Cancer Research And Treatment 2022, 198: 177-181. PMID: 36542252, DOI: 10.1007/s10549-022-06829-4.
• Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessmentFayanju O, Oyekunle T, Thomas S, Ingraham K, Fish L, Greenup R, Oeffinger K, Zafar S, Hyslop T, Hwang E, Patierno S, Barrett N. Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment. The American Journal Of Surgery 2022, 225: 617-629. PMID: 36411107, PMCID: PMC10085670, DOI: 10.1016/j.amjsurg.2022.10.059.
• Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021Chehayeb R, Hood A, Wang X, Miksad R, Mougalian S, Lustberg M, Wang S, Greenup R, Pusztai L, Kunst N. Treatment Sequencing Patterns and Associated Direct Medical Costs of Metastatic Breast Cancer Care in the United States, 2011 to 2021. JAMA Network Open 2022, 5: e2244204. PMID: 36445704, PMCID: PMC9709649, DOI: 10.1001/jamanetworkopen.2022.44204.
• Ancillary treatment referrals and visits after breast cancer surgery in a sociodemographically diverse population.Chan V, Heller D, Berger E, Capozza S, Greenup R, Sanft T. Ancillary treatment referrals and visits after breast cancer surgery in a sociodemographically diverse population. Journal Of Clinical Oncology 2022, 40: 1533-1533. DOI: 10.1200/jco.2022.40.16_suppl.1533.
• Treatment patterns and medical costs of metastatic breast cancer care in the United States.Jaber Chehayeb R, Hood A, Mougalian S, Lustberg M, Wang S, Greenup R, Pusztai L, Kunst N. Treatment patterns and medical costs of metastatic breast cancer care in the United States. Journal Of Clinical Oncology 2022, 40: e18834-e18834. DOI: 10.1200/jco.2022.40.16_suppl.e18834.
• Abstract P4-10-13: Area deprivation index and rurality in relation to financial toxicity among breast cancer surgical patients - Investigating geospatial differences in risk profilesCorkum J, Zhu V, Agbafe V, Chu C, Colen J, Greenup R, Offodile A. Abstract P4-10-13: Area deprivation index and rurality in relation to financial toxicity among breast cancer surgical patients - Investigating geospatial differences in risk profiles. Cancer Research 2022, 82: p4-10-13-p4-10-13. DOI: 10.1158/1538-7445.sabcs21-p4-10-13.
• ASO Visual Abstract: Association of Medicaid Expansion on Postmastectomy Reconstruction RatesLe Blanc J, Golshan M, Lannin D, Greenup R, Berger E, Saridakis A, Horowitz N, Zanieski G, Avraham T, Mastrioanni M, Park T. ASO Visual Abstract: Association of Medicaid Expansion on Postmastectomy Reconstruction Rates. Annals Of Surgical Oncology 2022, 29: 2191-2192. DOI: 10.1245/s10434-021-10944-9.
• Racial and Ethnic Disparities in Surgical Outcomes after Postmastectomy Breast ReconstructionSarver M, Rames J, Ren Y, Greenup R, Hwang E, Hollenbeck S, Hyslop T, Butler P, Phillips B, Fayanju O. Racial and Ethnic Disparities in Surgical Outcomes after Postmastectomy Breast Reconstruction. Journal Of The American College Of Surgeons 2021, 233: s29. DOI: 10.1016/j.jamcollsurg.2021.07.034.
• ASO Visual Abstract: Dissatisfaction After Post-Mastectomy Breast Reconstruction: A Mixed-Methods StudyShammas R, Fish L, Sergesketter A, Offodile A, Phillips B, Oshima S, Lee C, Hollenbeck S, Greenup R. ASO Visual Abstract: Dissatisfaction After Post-Mastectomy Breast Reconstruction: A Mixed-Methods Study. Annals Of Surgical Oncology 2021, 28: 720-721. DOI: 10.1245/s10434-021-10779-4.
• ASO Visual Abstract: Contralateral Axillary Nodal Metastases—Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?Nash A, Thomas S, Plichta J, Fayanju O, Hwang E, Greenup R, Rosenberger L. ASO Visual Abstract: Contralateral Axillary Nodal Metastases—Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer? Annals Of Surgical Oncology 2021, 28: 608-609. DOI: 10.1245/s10434-021-10605-x.
• Assessing the use of low value oncology care following the release of Choosing Wisely guidelines.Gunn A, Sarver M, Kaplan S, Zafar Y, Greenup R. Assessing the use of low value oncology care following the release of Choosing Wisely guidelines. Journal Of Clinical Oncology 2021, 39: e18861-e18861. DOI: 10.1200/jco.2021.39.15_suppl.e18861.
• Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program (NC BCCCP): A review of 90,000 women.Tait S, Ren Y, Horton C, Oshima S, Thomas S, Wright S, Caesar A, Plichta J, Hwang E, Greenup R, Rosenberger L, DiLalla G, Menendez C, Tolnitch L, Hyslop T, Nelson D, Fayanju O. Characterizing participants in the North Carolina Breast and Cervical Cancer Control Program (NC BCCCP): A review of 90,000 women. Journal Of Clinical Oncology 2020, 38: 101-101. DOI: 10.1200/jco.2020.38.29_suppl.101.
• The effect of body mass index (BMI) on survival in patients with breast cancer and obesity-associated conditions.Caddell K, Ren Y, Sampathkumar A, Almond C, Ladipo O, Champ C, Rosenberger L, Greenup R, Plichta J, DiLalla G, Menendez C, Tolnitch L, Hwang E, Hyslop T, Fayanju O. The effect of body mass index (BMI) on survival in patients with breast cancer and obesity-associated conditions. Journal Of Clinical Oncology 2020, 38: 203-203. DOI: 10.1200/jco.2020.38.29_suppl.203.
• Contralateral Prophylactic Mastectomy and Financial Toxicity: A Single-Institution Propensity-Matched AnalysisAsaad M, Boukovalas S, Chu C, Lin Y, Checka C, Greenup R, Offodile A. Contralateral Prophylactic Mastectomy and Financial Toxicity: A Single-Institution Propensity-Matched Analysis. Journal Of The American College Of Surgeons 2020, 231: e82. DOI: 10.1016/j.jamcollsurg.2020.08.205.
• Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysisSpring L, Fell G, Arfe A, Sharma C, Greenup R, Reynolds K, Smith B, Alexander B, Moy B, Isakoff S, Parmigiani G, Trippa L, Bardia A. Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis. Clinical Cancer Research 2020, 26: 2838-2848. PMID: 32046998, PMCID: PMC7299787, DOI: 10.1158/1078-0432.ccr-19-3492.
• Missing data in breast cancer: Relationship with survival in national databases.Plichta J, Rushing C, Lewis H, Blazer D, Hyslop T, Greenup R. Missing data in breast cancer: Relationship with survival in national databases. Journal Of Clinical Oncology 2020, 38: e19114-e19114. DOI: 10.1200/jco.2020.38.15_suppl.e19114.
• Abstract P3-08-10: Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER+/HER-, lymph node negative breast cancerSammons S, Ren Y, Force J, Fayanju O, Rosenberger L, Plichta J, Kimmick G, Westbrook K, Dent S, Anders C, Thomas S, Hyslop T, Hwang E, Marcom P, Greenup R. Abstract P3-08-10: Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER+/HER-, lymph node negative breast cancer. Cancer Research 2020, 80: p3-08-10-p3-08-10. DOI: 10.1158/1538-7445.sabcs19-p3-08-10.
• Breast SurgeryGreenup R, Rosenberger L. Breast Surgery. 2020, 183-188. DOI: 10.1007/978-3-030-29271-3_20.
• Cost of Reconstruction: A Qualitative Study of Women after Breast CancerLane W, Rushing C, Mundy L, Shammas R, Hollenbeck S, Fish L, Greenup R. Cost of Reconstruction: A Qualitative Study of Women after Breast Cancer. Journal Of The American College Of Surgeons 2019, 229: s147. DOI: 10.1016/j.jamcollsurg.2019.08.325.
• Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular CarcinomaThornton M, Williamson H, Westbrook K, Greenup R, Plichta J, Rosenberger L, Gupta A, Hyslop T, Hwang E, Fayanju O. Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma. Annals Of Surgical Oncology 2019, 26: 3166-3177. PMID: 31342392, PMCID: PMC6736696, DOI: 10.1245/s10434-019-07564-9.
• Ductal carcinoma in situ in the elderly: what is the ideal treatment plan?DeChant C, Thomas S, Rosenberger L, Fayanju O, Greenup R, Hwang E, Plichta J. Ductal carcinoma in situ in the elderly: what is the ideal treatment plan? Journal Of Unexplored Medical Data 2019, 4: null-null. DOI: 10.20517/2572-8180.2019.07.
• Abstract GS2-03: Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and mortality, stratified by breast cancer subtypes and adjuvant chemotherapy usage: Individual patient-level meta-analyses of over 27,000 patientsSpring L, Fell G, Arfe A, Trippa L, Greenup R, Reynolds K, Smith B, Moy B, Isakoff S, Parmigiani G, Bardia A. Abstract GS2-03: Pathological complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and mortality, stratified by breast cancer subtypes and adjuvant chemotherapy usage: Individual patient-level meta-analyses of over 27,000 patients. Cancer Research 2019, 79: gs2-03-gs2-03. DOI: 10.1158/1538-7445.sabcs18-gs2-03.
• Abstract PD6-08: Medicare costs for women after breast cancer: Preparing for survivorshipGreenup R, Yashkin A, Gorbunova G, Akusevich I, Hwang E. Abstract PD6-08: Medicare costs for women after breast cancer: Preparing for survivorship. Cancer Research 2019, 79: pd6-08-pd6-08. DOI: 10.1158/1538-7445.sabcs18-pd6-08.
• The quality of breast cancer quality measures.Lane W, Rushing C, Nussbaum D, Blazer D, Greenup R. The quality of breast cancer quality measures. Journal Of Clinical Oncology 2018, 36: 108-108. DOI: 10.1200/jco.2018.36.30_suppl.108.
• The costs of breast cancer care: Patient-reported experiences and preferences for transparency.Greenup R, Rushing C, Fish L, Hyslop T, Peppercorn J, Wheeler S, Zafar Y, Myers E, Hwang E. The costs of breast cancer care: Patient-reported experiences and preferences for transparency. Journal Of Clinical Oncology 2018, 36: 207-207. DOI: 10.1200/jco.2018.36.30_suppl.207.
• The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT)Fayanju O, Ren Y, Thomas S, Greenup R, Plichta J, Rosenberger L, Tamirisa N, Force J, Boughey J, Hyslop T, Hwang E. The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT). Annals Of Surgery 2018, 268: 591-601. PMID: 30048319, PMCID: PMC6496955, DOI: 10.1097/sla.0000000000002953.
• Evolving Patterns of Postmastectomy Breast Reconstruction by Race/Ethnicity: A Surveillance, Epidemiology, and End Results Analysis from 1998 to 2014Sergesketter A, Thomas S, Lane W, Orr J, Fayanju O, Greenup R, Hollenbeck S. Evolving Patterns of Postmastectomy Breast Reconstruction by Race/Ethnicity: A Surveillance, Epidemiology, and End Results Analysis from 1998 to 2014. Journal Of The American College Of Surgeons 2018, 227: s207. DOI: 10.1016/j.jamcollsurg.2018.07.453.
• Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and SurvivalTamirisa N, Thomas S, Fayanju O, Greenup R, Rosenberger L, Hyslop T, Hwang E, Plichta J. Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival. Annals Of Surgical Oncology 2018, 25: 2890-2898. PMID: 29968029, PMCID: PMC6404232, DOI: 10.1245/s10434-018-6595-2.
• The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.Tamirisa N, Vernia H, Thomas S, Westbrook K, Greenup R, Plichta J, Rosenberger L, Hyslop T, Hwang E, Fayanju O. The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma. Journal Of Clinical Oncology 2018, 36: 587-587. DOI: 10.1200/jco.2018.36.15_suppl.587.
• Restaging de novo metastatic breast cancer to refine prognostic estimates.Plichta J, Thomas S, Sergesketter A, Fayanju O, Greenup R, Rosenberger L, Kimmick G, Hyslop T, Hwang E. Restaging de novo metastatic breast cancer to refine prognostic estimates. Journal Of Clinical Oncology 2018, 36: e13083-e13083. DOI: 10.1200/jco.2018.36.15_suppl.e13083.
• Abstract P6-10-01: Incidence and mortality among breast cancer patients < 40 years old: U.S. trends from 1992-2014Oyekunle T, Thomas S, Greenup R, Hyslop T, Blackwell K. Abstract P6-10-01: Incidence and mortality among breast cancer patients < 40 years old: U.S. trends from 1992-2014. Cancer Research 2018, 78: p6-10-01-p6-10-01. DOI: 10.1158/1538-7445.sabcs17-p6-10-01.
• The Effect of Hospital Volume on Breast Cancer MortalityGreenup R, Obeng-Gyasi S, Thomas S, Houck K, Lane W, Blitzblau R, Hyslop T, Hwang E. The Effect of Hospital Volume on Breast Cancer Mortality. Annals Of Surgery 2018, 267: 375-381. PMID: 27893532, PMCID: PMC5994238, DOI: 10.1097/sla.0000000000002095.
• Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional StudyJakub J, Peled A, Gray R, Greenup R, Kiluk J, Sacchini V, McLaughlin S, Tchou J, Vierkant R, Degnim A, Willey S. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study. JAMA Surgery 2018, 153: 123-129. PMID: 28903167, PMCID: PMC5838709, DOI: 10.1001/jamasurg.2017.3422.
• The Impact of Autologous Breast Reconstruction on Body Mass Index Patterns in Breast Cancer PatientsCho E, Shammas R, Glener A, Greenup R, Hwang E, Hollenbeck S. The Impact of Autologous Breast Reconstruction on Body Mass Index Patterns in Breast Cancer Patients. Plastic & Reconstructive Surgery 2017, 140: 1121-1131. PMID: 29176410, DOI: 10.1097/prs.0000000000003841.
• Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer.Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, Coopey S, Taghian A, Hughes K, Isakoff S, Ellisen L, Smith B, Specht M, Moy B, Bardia A. Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer. Journal Of The National Comprehensive Cancer Network 2017, 15: 1216-1223. PMID: 28982747, DOI: 10.6004/jnccn.2017.0158.
• Association Between Targeted HER-2 Therapy and Breast Reconstruction Outcomes: A Propensity Score-Matched AnalysisShammas R, Cho E, Glener A, Poveromo L, Mundy L, Greenup R, Blackwell K, Hollenbeck S. Association Between Targeted HER-2 Therapy and Breast Reconstruction Outcomes: A Propensity Score-Matched Analysis. Journal Of The American College Of Surgeons 2017, 225: 731-739.e1. PMID: 28985927, DOI: 10.1016/j.jamcollsurg.2017.08.023.
• Quality in Cancer Care: An Assessment of the American College of Surgeons Commission on Cancer Quality MeasuresNussbaum D, Blazer D, Greenup R, Sun Z, Yerokun B, Rushing C, Niedzwiecki D. Quality in Cancer Care: An Assessment of the American College of Surgeons Commission on Cancer Quality Measures. Journal Of The American College Of Surgeons 2017, 225: s125. DOI: 10.1016/j.jamcollsurg.2017.07.275.
• Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian CancerGamble C, Havrilesky L, Myers E, Chino J, Hollenbeck S, Plichta J, Kelly Marcom P, Shelley Hwang E, Kauff N, Greenup R. Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer. Annals Of Surgical Oncology 2017, 24: 3116-3123. PMID: 28699130, PMCID: PMC5990891, DOI: 10.1245/s10434-017-5995-z.
• Breast Cancer after AugmentationCho E, Shammas R, Phillips B, Greenup R, Hwang E, Hollenbeck S. Breast Cancer after Augmentation. Plastic & Reconstructive Surgery 2017, 139: 1240e-1249e. PMID: 28538550, DOI: 10.1097/prs.0000000000003342.
• The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database.Campbell B, Thomas S, Ong C, Greenup R, Plichta J, Rosenberger L, Force J, Hyslop T, Hwang E, Fayanju O. The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database. Journal Of Clinical Oncology 2017, 35: 1570-1570. DOI: 10.1200/jco.2017.35.15_suppl.1570.
• A population-based analysis of treatment and outcomes in 2,500 metaplastic breast cancer patients.Ong C, Thomas S, Campbell B, Greenup R, Plichta J, Rosenberger L, Force J, Hyslop T, Hwang E, Fayanju O. A population-based analysis of treatment and outcomes in 2,500 metaplastic breast cancer patients. Journal Of Clinical Oncology 2017, 35: 532-532. DOI: 10.1200/jco.2017.35.15_suppl.532.
• Impact of insurance status on treatment for stage 0-IV breast cancer.Greenup R, Thomas S, Fayanju O, Hyslop T, Hwang E. Impact of insurance status on treatment for stage 0-IV breast cancer. Journal Of Clinical Oncology 2017, 35: 6532-6532. DOI: 10.1200/jco.2017.35.15_suppl.6532.
• Role of axillary node dissection after mastectomy with positive sentinel nodes.Park T, Thomas S, Greenup R, Hwang E. Role of axillary node dissection after mastectomy with positive sentinel nodes. Journal Of Clinical Oncology 2017, 35: 554-554. DOI: 10.1200/jco.2017.35.15_suppl.554.
• Temporal associations between prognostic indicators and overall survival after breast cancer.Plichta J, Thomas S, Fayanju O, Rosenberger L, Park T, Hyslop T, Greenup R, Hwang E. Temporal associations between prognostic indicators and overall survival after breast cancer. Journal Of Clinical Oncology 2017, 35: e18144-e18144. DOI: 10.1200/jco.2017.35.15_suppl.e18144.
• Miniature spectral imaging device for wide-field quantitative functional imaging of the morphological landscape of breast tumor marginsNichols B, Llopis A, Palmer G, McCachren S, Senlik O, Miller D, Brooke M, Jokerst N, Geradts J, Greenup R, Ramanujam N. Miniature spectral imaging device for wide-field quantitative functional imaging of the morphological landscape of breast tumor margins. Journal Of Biomedical Optics 2017, 22: 026007-026007. PMID: 28241273, PMCID: PMC5321165, DOI: 10.1117/1.jbo.22.2.026007.
• Self-Reported Factors Associated with Surgeon Comfort with Performing Contralateral Prophylactic MastectomyBellavance E, Yao K, Greenup R, Keune J, Lynch J, Colyar D, Tilburt J, Hlubocky F, Peppercorn J. Self-Reported Factors Associated with Surgeon Comfort with Performing Contralateral Prophylactic Mastectomy. Journal Of The American College Of Surgeons 2016, 223: e16-e17. DOI: 10.1016/j.jamcollsurg.2016.08.046.
• The Promise and Perils of Shared Decision-Making in Clinical PracticeGreenup R, Peppercorn J. The Promise and Perils of Shared Decision-Making in Clinical Practice. 2016, 293-305. DOI: 10.1007/978-1-4939-3486-7_21.
• Abstract 1439: Pathological complete response after neoadjuvant chemotherapy predicts improved survival in all major subtypes of breast cancer: systematic review and meta-analyses of over 18,000 patientsSpring L, Greenup R, Reynolds K, Smith B, Moy B, Bardia A. Abstract 1439: Pathological complete response after neoadjuvant chemotherapy predicts improved survival in all major subtypes of breast cancer: systematic review and meta-analyses of over 18,000 patients. Cancer Research 2016, 76: 1439-1439. DOI: 10.1158/1538-7445.am2016-1439.
• The Impact of the Affordable Care Act on North Carolinian Breast Cancer Patients Seeking Financial Support for TreatmentObeng-Gyasi S, Tolnitch L, Greenup R, Shelley Hwang E. The Impact of the Affordable Care Act on North Carolinian Breast Cancer Patients Seeking Financial Support for Treatment. Annals Of Surgical Oncology 2016, 23: 3412-3417. PMID: 27411550, PMCID: PMC5994757, DOI: 10.1245/s10434-016-5311-3.
• Value of prophylactic mastectomy in BRCA mutation carriers with ovarian cancerGamble C, Havrilesky L, Hollenbeck S, Myers E, Greenup R. Value of prophylactic mastectomy in BRCA mutation carriers with ovarian cancer. Gynecologic Oncology 2016, 141: 58-59. DOI: 10.1016/j.ygyno.2016.04.173.
• Can Vascular Patterns on Preoperative Magnetic Resonance Imaging Help Predict Skin Necrosis after Nipple-Sparing Mastectomy?Bahl M, Pien I, Buretta K, Hwang E, Greenup R, Ghate S, Hollenbeck S. Can Vascular Patterns on Preoperative Magnetic Resonance Imaging Help Predict Skin Necrosis after Nipple-Sparing Mastectomy? Journal Of The American College Of Surgeons 2016, 223: 279-285. PMID: 27182036, DOI: 10.1016/j.jamcollsurg.2016.04.045.
• Surgeons’ Perspectives of Contralateral Prophylactic MastectomyBellavance E, Peppercorn J, Kronsberg S, Greenup R, Keune J, Lynch J, Collyar D, Magder L, Tilburt J, Hlubocky F, Yao K. Surgeons’ Perspectives of Contralateral Prophylactic Mastectomy. Annals Of Surgical Oncology 2016, 23: 2779-2787. PMID: 27169770, DOI: 10.1245/s10434-016-5253-9.
• Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.Altomare I, Irwin B, Zafar S, Houck K, Maloney B, Greenup R, Peppercorn J, Altomare I, Irwin B, Zafar S, Houck K, Maloney B, Greenup R, Peppercorn J. Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care. JCO Oncology Practice 2016, 12: e281-8, 247-8. PMID: 26883407, PMCID: PMC4960469, DOI: 10.1200/jop.2015.007401.
• A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancerWhitley M, Cardona D, Lazarides A, Spasojevic I, Ferrer J, Cahill J, Lee C, Snuderl M, Blazer D, Hwang E, Greenup R, Mosca P, Mito J, Cuneo K, Larrier N, O'Reilly E, Riedel R, Eward W, Strasfeld D, Fukumura D, Jain R, Lee W, Griffith L, Bawendi M, Kirsch D, Brigman B. A mouse-human phase 1 co-clinical trial of a protease-activated fluorescent probe for imaging cancer. Science Translational Medicine 2016, 8: 320ra4. PMID: 26738797, PMCID: PMC4794335, DOI: 10.1126/scitranslmed.aad0293.
• Combining Prophylactic Oophorectomy with Mastectomy Does Not Adversely Affect Surgical Outcomes: Results from the NSQIP DatabaseBlau J, Gamble C, Anolik R, Havrilesky L, Greenup R, Hollenbeck S. Combining Prophylactic Oophorectomy with Mastectomy Does Not Adversely Affect Surgical Outcomes: Results from the NSQIP Database. Journal Of The American College Of Surgeons 2015, 221: s113. DOI: 10.1016/j.jamcollsurg.2015.07.263.
• Vascular Patterns on Preoperative Breast MRI Predict Ischemia and Necrosis after Nipple-Sparing MastectomyPien I, Bahl M, Buretta K, Greenup R, Ghate S, Hollenbeck S. Vascular Patterns on Preoperative Breast MRI Predict Ischemia and Necrosis after Nipple-Sparing Mastectomy. Journal Of The American College Of Surgeons 2015, 221: s120. DOI: 10.1016/j.jamcollsurg.2015.07.282.
• Trends in Treatment Patterns and Outcomes for Ductal Carcinoma in SituWorni M, Akushevich I, Greenup R, Sarma D, Ryser M, Myers E, Hwang E. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma in Situ. Journal Of The National Cancer Institute 2015, 107: djv263. PMID: 26424776, PMCID: PMC4707192, DOI: 10.1093/jnci/djv263.
• Evaluation of Pathologic Nipple Discharge: What is the Added Diagnostic Value of MRI?Bahl M, Baker J, Greenup R, Ghate S. Evaluation of Pathologic Nipple Discharge: What is the Added Diagnostic Value of MRI? Annals Of Surgical Oncology 2015, 22: 435-441. PMID: 26249144, DOI: 10.1245/s10434-015-4792-9.
• Abstract SY36-03: Intraoperative molecular imaging with protease-activated fluorescent imaging agentsWhitley M, Cardona D, Blazer D, Hwang S, Greenup R, Mosca P, Cahill J, Mito J, Cuneo K, Larrier N, O'Reilly E, Spasojevic I, Riedel R, Eward W, Griffith L, Bawendi M, Ferrer J, Strasfeld D, Lee W, Brigman B, Kirsch D. Abstract SY36-03: Intraoperative molecular imaging with protease-activated fluorescent imaging agents. 2015, sy36-03-sy36-03. DOI: 10.1158/1538-7445.am2015-sy36-03.
• Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast CancerHolmes D, Colfry A, Czerniecki B, Dickson-Witmer D, Francisco Espinel C, Feldman E, Gallagher K, Greenup R, Herrmann V, Kuerer H, Malik M, Manahan E, O’Neill J, Patel M, Sebastian M, Wheeler A, Kass R. Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer. Annals Of Surgical Oncology 2015, 22: 3184-3190. PMID: 26224406, DOI: 10.1245/s10434-015-4753-3.
• Diagnostic Value of Ultrasound in Female Patients With Nipple Discharge.Bahl M, Baker J, Greenup R, Ghate S. Diagnostic Value of Ultrasound in Female Patients With Nipple Discharge. American Journal Of Roentgenology 2015, 205: 203-8. PMID: 26102400, DOI: 10.2214/ajr.14.13354.
• A Quantitative Diffuse Reflectance Imaging (QDRI) System for Comprehensive Surveillance of the Morphological Landscape in Breast Tumor MarginsNichols B, Schindler C, Brown J, Wilke L, Mulvey C, Krieger M, Gallagher J, Geradts J, Greenup R, Von Windheim J, Ramanujam N. A Quantitative Diffuse Reflectance Imaging (QDRI) System for Comprehensive Surveillance of the Morphological Landscape in Breast Tumor Margins. PLOS ONE 2015, 10: e0127525. PMID: 26076123, PMCID: PMC4468201, DOI: 10.1371/journal.pone.0127525.
• Abstract P1-10-02: Adjuvant radiation after lumpectomy: A cost comparison of treatment patterns in 43,247 women from the National Cancer Data BaseGreenup R, Blitzblau R, Houck K, Horton J, Howie L, Palta M, Mackey A, Scheri R, Sosa J, Taghian A, Peppercorn J, Smith B, Hwang E. Abstract P1-10-02: Adjuvant radiation after lumpectomy: A cost comparison of treatment patterns in 43,247 women from the National Cancer Data Base. 2015, p1-10-02-p1-10-02. DOI: 10.1158/1538-7445.sabcs14-p1-10-02.
• Abstract P1-15-10: Low utilization of hypofractionated radiotherapy for the treatment of early-stage breast cancer in the USMowery Y, Greenup R, Houck K, Palta M, Horton J, Hwang E, Sosa J, Blitzblau R. Abstract P1-15-10: Low utilization of hypofractionated radiotherapy for the treatment of early-stage breast cancer in the US. 2015, p1-15-10-p1-15-10. DOI: 10.1158/1538-7445.sabcs14-p1-15-10.
• Abstract P3-07-22: Predictors of neoadjuvant chemotherapy use in women with breast cancer: A review of 169,329 patients from the American College of Surgeons' National Cancer DatabaseHowie L, Greenup R, Houck K, Sosa J, Hwang E, Peppercorn J. Abstract P3-07-22: Predictors of neoadjuvant chemotherapy use in women with breast cancer: A review of 169,329 patients from the American College of Surgeons' National Cancer Database. 2015, p3-07-22-p3-07-22. DOI: 10.1158/1538-7445.sabcs14-p3-07-22.
• Abstract P5-15-11: The distress screening tool: Initial experience with electronically curated patient reported measuresHwang S, Power S, Stashko I, Blitzblau R, Greenup R, Horton J, Westbrook K, Blackwell K, Sperling H, Peppercorn J, Kimmick G, Marcom K. Abstract P5-15-11: The distress screening tool: Initial experience with electronically curated patient reported measures. 2015, p5-15-11-p5-15-11. DOI: 10.1158/1538-7445.sabcs14-p5-15-11.
• Management of Positive Sub‐areolar/Nipple Duct Margins in Nipple‐Sparing MastectomiesCamp M, Coopey S, Tang R, Colwell A, Specht M, Greenup R, Gadd M, Brachtel E, Austen W, Smith B. Management of Positive Sub‐areolar/Nipple Duct Margins in Nipple‐Sparing Mastectomies. The Breast Journal 2014, 20: 402-407. PMID: 24890641, DOI: 10.1111/tbj.12279.
• Trends in treatment patterns and outcomes for DCIS patients: A SEER population-based analysis.Worni M, Greenup R, Mackey A, Akushevich I, Hwang S. Trends in treatment patterns and outcomes for DCIS patients: A SEER population-based analysis. Journal Of Clinical Oncology 2014, 32: 1007-1007. DOI: 10.1200/jco.2014.32.15_suppl.1007.
• Physician experience and attitudes toward addressing the cost of cancer care.Altomare I, Irwin B, Zafar Y, Houck K, Maloney B, Greenup R, Peppercorn J. Physician experience and attitudes toward addressing the cost of cancer care. Journal Of Clinical Oncology 2014, 32: 6561-6561. DOI: 10.1200/jco.2014.32.15_suppl.6561.
• Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast CancerGreenup R, Peppercorn J, Worni M, Hwang E. Cost Implications of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery with Whole Breast Irradiation in Stage I and II Invasive Breast Cancer. Annals Of Surgical Oncology 2014, 21: 1512-1514. PMID: 24577813, DOI: 10.1245/s10434-014-3605-x.
• Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling CohortGreenup R, Buchanan A, Lorizio W, Rhoads K, Chan S, Leedom T, King R, McLennan J, Crawford B, Kelly Marcom P, Shelley Hwang E. Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort. Annals Of Surgical Oncology 2013, 20: 3254-3258. PMID: 23975317, DOI: 10.1245/s10434-013-3205-1.
• New Treatment Paradigms for Patients with Ductal Carcinoma In SituMackey A, Greenup R, Hwang E. New Treatment Paradigms for Patients with Ductal Carcinoma In Situ. Current Breast Cancer Reports 2013, 5: 86-98. DOI: 10.1007/s12609-013-0109-9.
• Application of ACOSOG Z0011 Criteria Reduces Perioperative CostsCamp M, Greenup R, Taghian A, Coopey S, Specht M, Gadd M, Hughes K, Smith B. Application of ACOSOG Z0011 Criteria Reduces Perioperative Costs. Annals Of Surgical Oncology 2012, 20: 836-841. PMID: 23010735, DOI: 10.1245/s10434-012-2664-0.
• Cost Comparison of Radiation Treatment Options After Lumpectomy for Breast CancerGreenup R, Camp M, Taghian A, Buckley J, Coopey S, Gadd M, Hughes K, Specht M, Smith B. Cost Comparison of Radiation Treatment Options After Lumpectomy for Breast Cancer. Annals Of Surgical Oncology 2012, 19: 3275-3281. PMID: 22851048, DOI: 10.1245/s10434-012-2546-5.
• Association of pathologic complete response following neoadjuvant chemotherapy with survival among young women with breast cancer.Greenup R, Bardia A, Buckley J, Niemierko A, Camp M, Coopey S, Gadd M, Schapira L, Taghian A, Smith B, Specht M. Association of pathologic complete response following neoadjuvant chemotherapy with survival among young women with breast cancer. Journal Of Clinical Oncology 2012, 30: 1122-1122. DOI: 10.1200/jco.2012.30.15_suppl.1122.
• Incidence and Risk Factors for Venous Thromboembolism in Critically Ill Children After TraumaHanson S, Punzalan R, Greenup R, Liu H, Sato T, Havens P. Incidence and Risk Factors for Venous Thromboembolism in Critically Ill Children After Trauma. Journal Of Trauma And Acute Care Surgery 2010, 68: 52-56. PMID: 20065757, DOI: 10.1097/ta.0b013e3181a74652.
• Quality of life in cancer survivors: The surgeon's roleGreenup R, Lal A, Walsh M, Pappas S, Trentham-Dietz A. Quality of life in cancer survivors: The surgeon's role. Journal Of The American College Of Surgeons 2009, 209: s106. DOI: 10.1016/j.jamcollsurg.2009.06.264.
• QS114. Patient Perception of Physician Commitment Affects Quality of Life in Breast Cancer SurvivorsGreenup R, Lal A, Trentham-Dietz A. QS114. Patient Perception of Physician Commitment Affects Quality of Life in Breast Cancer Survivors. Journal Of Surgical Research 2009, 151: 287. DOI: 10.1016/j.jss.2008.11.410.
• Urgent surgical issues in children with special health care needs: A brief report.Greenup R, Calkins C. Urgent surgical issues in children with special health care needs: A brief report. Journal Of Pediatric Rehabilitation Medicine 2009, 2: 101-6. PMID: 21791801, DOI: 10.3233/prm-2009-0069.
• The Other Side of the StethoscopeGreenup R. The Other Side of the Stethoscope. Academic Psychiatry 2008, 32: 1-2. PMID: 18270273, DOI: 10.1176/appi.ap.32.1.1.
• Perspectives on Being a Mom and a Surgical Trainee. Juggling these Roles?Greenup R. Perspectives on Being a Mom and a Surgical Trainee. Juggling these Roles? Journal Of Surgical Education 2006, 63: 297-298. PMID: 16843785, DOI: 10.1016/j.cursur.2006.04.002.